Expert Review of Anti-Infective Therapy

Article	Citations
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	131
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	111
Challenges in preserving antibiotic effectiveness: time for a novel approach	87
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	55
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	51
Neonatal ocular prophylaxis in the United States: is it still necessary?	51
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	47
Visceral leishmaniasis elimination in India: progress and the road ahead	47
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	41
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	39
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	36
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	34
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	34
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	34
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	34
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	31
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	31
Reemergence of monkeypox: prevention and management	31
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	30
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	29
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	28
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	27
Identifying predictors of treatment failure with community-acquired pneumonia: an update	26
Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?	26

Treatment of vaginitis caused by non-albicans Candida species	26
Difficile to treat: advanced management strategies in difficult to treat Clostridioides difficile infections	25
Can Saccharomyces cerevisiae be used as a therapeutic agent for vulvovaginal candidiasis?	24
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?	23
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective	21
Treatment of pulmonary mucormycosis: current concepts	21
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin	20
Diagnostic and clinical management of Candida auris infections in immunocompromised patients	20
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections	20
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline	20
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta	19
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases	19
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges	19
One health and resistant fungi: a challenging balancing act between food security and patient survival	19
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases	19
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges	19
Advances in therapeutic strategies against Mycobacterium marinum infection	19
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures	18
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19	18
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development	18
Diagnostic and management strategies for chronic hepatitis E infection	17
Updates on Candida albicans infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies	17
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance	17
Infliximab as a potential treatment for COVID-19	17
Statement of Retraction	16
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review	16
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?	16
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections	15
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential	15
Correction	15
Risk of HIV viral rebound after SARS-CoV-2 infection among people living with HIV on antiretroviral therapy: a retrospective matched cohort study	15
Diagnosing fungal infections in clinical practice: a narrative review	15
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India	15
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat	15
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury	14
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae	14
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches	14
The serological dilemma: rethinking syphilis treatment evaluation	13
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)	13
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae	13
Monoclonal antibodies for the treatment of COVID-19 infection in children	13
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana	13
The evolving debate around screening for Chlamydia trachomatis	13
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection	12
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study	12
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea	12
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas	12
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	11
Challenges associated with pertussis detection, monitoring, and vaccination in adults	11
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	11

Precision antibiotic treatment in intensive care unit-acquired lower respiratory tract infections (ICU-LRTIs): contemporary concepts and future directions	11
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae	11
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations	11
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?	11
Targeted screening for HTLV-1 infection in endemic and non-endemic regions: a global public health priority	11
How can we tackle the overuse of antibiotics in low- and middle-income countries?	11
Tocilizumab for the treatment of COVID-19	11
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers	10
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?	10
New insights into the treatment of acute otitis media	10
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	10
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	10
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents	10
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t	10
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America	10
Gram-positive infections in special populations. Expert view on the role of dalbavancin	10
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals	10
Unmet targets: evaluating vancomycin use and predictive factors of target attainment in hemodialysis patients	10
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis	10
How do we best manage Clostridioides difficle infections in the elderly?	10
A 96-week efficacy and safety of BIC/FTC/TAF in ART-naïve HIV-1 infected patients in China	10
Now that griseofulvin is not available, what to do with tinea capitis treatments?	10
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	9
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients	9
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo	9
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan	9
Diagnosis of urinary tract infections in the pediatric population – current practices, advances and progress	9
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	9
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	9
Global importance of new treatment strategies to efforts to control hepatitis B virus	9
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects	9
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients	9
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance	9
Comparative effectiveness of ceftaroline plus vancomycin or daptomycin versus vancomycin or daptomycin monotherapy for MRSA bacteremia: an updated systematic review and meta-analysis	9
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	9
Artificial intelligence and prescription of antibiotic therapy: present and future	9
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV	8
Efficacy and safety of Gepotidacin versus standard of-care antibiotics for the treatment of uncomplicated urogenital infections in adults and adolescents: a systematic review and meta-analysis	8
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis	8
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options	8
An update on antimicrobial selection and duration for intra-abdominal infections	8
An update on newer antifungals	8
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta	8
High frequency and molecular characterization of ESBL-producing Enterobacteriaceae isolated from wound infections in North Lebanon	8
The effect of combination antibiotic therapy on mortality in patients with sepsis or septic shock due to Pseudomonas aeruginosa bloodstream infections: a	8
Past, present, and future perspectives on aztreonam and avibactam	8
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV	7
Introduction and spread of NDM-producing Enterobacterales and Acinetobacter baumannii into Middle Eastern countries: a molecular-based hypothesis	7
Host defense mechanisms against Candida auris	7
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose	7
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow	7
Effectiveness of bundles to prevent surgical site infections in cranial neurosurgery: systematic review, meta-analysis, and GRADE evaluation	7
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	7
The prevalence of antimicrobial drug resistance of non-typhoidal Salmonella in human infections in sub-Saharan Africa: a systematic review and meta-analysis	7
Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection	7
Nucleos(t)ide analogue treatment in hepatitis B: to stop or not to stop?	7
Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak	7
Can probiotics replace antibiotics? Not yet, says the evidence	7
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation	7
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	7
Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?	7
Brincidofovir in the Era of Mpox	7
Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review	7
Non-cancerous complications in HTLV-1 carriers	7
HTLV-I associated bronchioloalveolar disorder (HABA): disease concept and differential diagnosis of an unsolved disease entity	7
Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis	7
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	7
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	7
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa	6
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	6
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)	6
Update on the diagnosis, pathophysiology and treatment strategies in non-HIV-associated cryptococcal meningoencephalitis	6
The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens	6
Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China	6
HIV postnatal prophylaxis: how long is long enough?	6
The impact of gender inequities on antimicrobial resistance in low-income countries: a comprehensive review	6
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	6
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain	6
How do we change our approach to COVID with the changing face of disease?	6
From guesswork to guidelines: advancing diagnostic stewardship in immunocompromised hosts	6

Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	6
Current perspectives of bacteriophage therapy for multidrug-resistant wound infections	6
Langya henipavirus outbreak	6
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis	6
A plain language summary of the safety and effectiveness of isavuconazole for the treatment of serious fungal disease in children with a weakened immune system	6
Genomic surveillance of Neisseria gonorrhoeae : a crucial tool in the global fight against antimicrobial resistance	6
Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years	6
Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis	5
Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence	5
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials	5
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution	5
Management of calcified cysticerci in the brain parenchyma: treating the dead parasite	5
Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii : a systematic review and meta-analysis	5
COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval	5
Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal againstHelicobacter pylori	5
Why do we urgently need a new treatment for cerebral aspergillosis?	5
Letter to the editor: “real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients”	5
The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis	5
Evaluating long-acting injectable HIV treatment: an update on cabotegravir and rilpivirine	5
Continuous care engagement in clinical practice: perspectives on selected current strategies for people with HIV in the United States	5
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice	5
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	5
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review	5
Omadacycline in treating community-based infections: a review and expert perspective	5
An evaluation of sipavibart for pre-exposure prophylaxis of COVID-19 in immunocompromised individuals	5
Antibiotic resistance in low- and middle-income countries: current practices and its global implications	5
Phage therapy: innovations, challenges, and future directions in combating superbugs and antibiotic resistance	5
Letter to the Editor: the earliest observation of bla NDM was in Israel	5
Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis	5
Personalized care approaches to hepatitis C therapy: recent advances and future directions	5
Candida auris biofilm: a review on model to mechanism conservation	5
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges	5
Nirmatrelvir/ritonavir: real world drug–drug interaction management experience	5
Artificial intelligence and its application in clinical microbiology	5
Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis	5
The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	5
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials	5
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	4
New therapeutic strategies for Mycobacterium abscessus pulmonary diseases – untapping the mycolic acid pathway	4
Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice	4
The efficacy and safety of hydroxychloroquine at different doses and courses for COVID-19 prevention: a systematic review and network meta-analysis	4
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections	4
Visited India? Metronidazole may not cure your Giardia infection	4
The antifungal pipeline for invasive fungal diseases: what does the future hold?	4
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?	4
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	4
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis	4
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants	4
Concerns with current Drug Laws regarding the purchasing antibiotics without a prescription in Pakistan; ways forward to assist the national action plan	4
Biosimilars as antivirals: opportunities and challenges	4
From Data to Decisions: Leveraging Large, Real-World Databases to Guide Clinical Practice in C. difficile Infections	4
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	4
Could the next disease X be pandemic of virus-induced encephalitis? what should be our first medical response?	4
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	4
Developing AWaRe-ness in primary care across low- and middle-income countries – a vital challenge for antibiotic stewardship programs	4
Sepsis management in the antimicrobial resistance era	4
Secnidazole: a treatment for trichomoniasis in adolescents and adults	4
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases	4
Immunocompromised patients and COVID-19: how do we protect those most at risk?	4
Antimicrobial management of complex biofilms in diabetic foot ulcers: a microbiological perspective	4
Therapeutic strategies to address monkeypox	4
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China	4
Penile microbiomes have important implications for HIV susceptibility and broader reproductive health	4
Impact of nirmatrelvir/ritonavir on the risk of long COVID in outpatients: a systematic review and meta-analysis	4